Olga Carroll, PhD
Olga has over 23 years of global pharma, biotech, and medical device experience. Her strategic and implementation experience in the development and commercialization of products allows her to deliver optimal regulatory strategies for clients. With previous roles at large, mid-size, and start-up companies, her subject matter expertise includes global regulatory clinical strategy, competitive and due diligence assessments, and evaluating product concept, opportunity, and investment potential.
Key areas of expertise
- Oncology/Hematology in both Pediatric and Adult Patients
- Neurology, Neurodegenerative Diseases, CNS
- Orphan rare, Ultra-rare Diseases in both Pediatric and Adult Patients
- Women’s Health
- Metabolic Disease